Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Ciprofloxacin-resistant Salmonella enterica Serotype Typhi, United States, 1999-2008.

Medalla F, Sjölund-Karlsson M, Shin S, Harvey E, Joyce K, Theobald L, Nygren BN, Pecic G, Gay K, Austin J, Stuart A, Blanton E, Mintz ED, Whichard JM, Barzilay EJ.

Emerg Infect Dis. 2011 Jun;17(6):1095-8. doi: 10.3201/eid/1706.100594.

2.

Antimicrobial resistance trends in blood culture positive Salmonella Typhi isolates from Pondicherry, India, 2005-2009.

Menezes GA, Harish BN, Khan MA, Goessens WH, Hays JP.

Clin Microbiol Infect. 2012 Mar;18(3):239-45. doi: 10.1111/j.1469-0691.2011.03546.x. Epub 2011 Jun 29.

3.

Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.

Gaind R, Paglietti B, Murgia M, Dawar R, Uzzau S, Cappuccinelli P, Deb M, Aggarwal P, Rubino S.

J Antimicrob Chemother. 2006 Dec;58(6):1139-44. Epub 2006 Oct 28.

PMID:
17071955
4.

First isolation of ciprofloxacin-resistant Salmonella enterica serovar Typhi in Taiwan.

Lee CJ, Su LH, Huang YC, Chiu CH.

J Microbiol Immunol Infect. 2013 Dec;46(6):469-73. doi: 10.1016/j.jmii.2013.01.002. Epub 2013 Mar 5.

5.

Antimicrobial susceptibility pattern and sequence analysis of DNA gyrase and DNA topoisomerase IV in Salmonella enterica serovars Typhi and Paratyphi A isolates with decreased susceptibility to ciprofloxacin.

Misra R, Thakare R, Amrin N, Prasad KN, Chopra S, Dhole TN.

Trans R Soc Trop Med Hyg. 2016 Aug;110(8):472-9. doi: 10.1093/trstmh/trw051. Epub 2016 Sep 12.

PMID:
27618918
6.

Ciprofloxacin-resistant Salmonella enterica serovar typhi from Kuwait with novel mutations in gyrA and parC genes.

Dimitrov T, Dashti AA, Albaksami O, Udo EE, Jadaon MM, Albert MJ.

J Clin Microbiol. 2009 Jan;47(1):208-11. doi: 10.1128/JCM.01161-08. Epub 2008 Oct 29.

7.

Induction of resistant mutants of Salmonella enterica serotype Typhi under ciprofloxacin selective pressure.

Dahiya S, Kapil A, Lodha R, Kumar R, Das BK, Sood S, Kabra SK.

Indian J Med Res. 2014 May;139(5):746-53.

8.

Emergence of Ciprofloxacin-Resistant Salmonella enterica Serovar Typhi in Italy.

García-Fernández A, Gallina S, Owczarek S, Dionisi AM, Benedetti I, Decastelli L, Luzzi I.

PLoS One. 2015 Jun 29;10(6):e0132065. doi: 10.1371/journal.pone.0132065. eCollection 2015.

9.

A Multicountry Molecular Analysis of Salmonella enterica Serovar Typhi With Reduced Susceptibility to Ciprofloxacin in Sub-Saharan Africa.

Al-Emran HM, Eibach D, Krumkamp R, Ali M, Baker S, Biggs HM, Bjerregaard-Andersen M, Breiman RF, Clemens JD, Crump JA, Cruz Espinoza LM, Deerin J, Dekker DM, Gassama Sow A, Hertz JT, Im J, Ibrango S, von Kalckreuth V, Kabore LP, Konings F, Løfberg SV, Meyer CG, Mintz ED, Montgomery JM, Olack B, Pak GD, Panzner U, Park SE, Razafindrabe JL, Rabezanahary H, Rakotondrainiarivelo JP, Rakotozandrindrainy R, Raminosoa TM, Schütt-Gerowitt H, Sampo E, Soura AB, Tall A, Warren M, Wierzba TF, May J, Marks F.

Clin Infect Dis. 2016 Mar 15;62 Suppl 1:S42-6. doi: 10.1093/cid/civ788.

10.

Bacteraemia with pleural effusions complicating typhoid fever caused by high-level ciprofloxacin-resistant Salmonella enterica serotype Typhi.

Mohanty S, Gaind R, Paglietti B, Paul P, Rubino S, Deb M.

Ann Trop Paediatr. 2010;30(3):233-40. doi: 10.1179/146532810X12786388978760.

PMID:
20828458
11.

Intermediate susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates in Lima, Peru.

García C, Lejon V, Horna G, Astocondor L, Vanhoof R, Bertrand S, Jacobs J.

J Clin Microbiol. 2014 Mar;52(3):968-70. doi: 10.1128/JCM.02663-13. Epub 2013 Dec 26.

12.

Reduced susceptibility to ciprofloxacin and gyra gene mutation in North Indian strains of Salmonella enterica serotype Typhi and serotype Paratyphi A.

Renuka K, Kapil A, Kabra SK, Wig N, Das BK, Prasad VV, Chaudhry R, Seth P.

Microb Drug Resist. 2004 Summer;10(2):146-53.

PMID:
15256030
14.

Novel restriction enzyme SSiI for the detection of mutation in GyrA gene of Salmonella enterica serovar Typhi.

Agrawal P, Kapila K, Kumar S, Ghosh AN, Maurya AK.

Indian J Pathol Microbiol. 2010 Jul-Sep;53(3):509-12. doi: 10.4103/0377-4929.68299.

15.

Plasmid-mediated quinolone resistance in isolates of Salmonella enterica serotype Typhi, USA.

Sjölund-Karlsson M, Howie R, Rickert R, Newton A, Gonzalez-Aviles G, Crump JA.

Int J Antimicrob Agents. 2015 Jan;45(1):88-90. doi: 10.1016/j.ijantimicag.2014.09.015. Epub 2014 Oct 24. No abstract available.

PMID:
25465527
16.

Antimicrobial susceptibility of travel-related Salmonella enterica serovar Typhi isolates detected in Switzerland (2002-2013) and molecular characterization of quinolone resistant isolates.

Nüesch-Inderbinen M, Abgottspon H, Sägesser G, Cernela N, Stephan R.

BMC Infect Dis. 2015 May 12;15:212. doi: 10.1186/s12879-015-0948-2.

17.

Drug resistance patterns in Salmonella enterica subspecies enterica serotype Typhi strains isolated over a period of two decades, with special reference to ciprofloxacin and ceftriaxone.

Nath G, Maurya P.

Int J Antimicrob Agents. 2010 May;35(5):482-5. doi: 10.1016/j.ijantimicag.2009.12.020. Epub 2010 Feb 25.

PMID:
20188522
18.

Molecular typing and resistance analysis of travel-associated Salmonella enterica serotype Typhi.

Tatavarthy A, Sanderson R, Peak K, Scilabro G, Davenhill P, Cannons A, Amuso P.

J Clin Microbiol. 2012 Aug;50(8):2631-8. doi: 10.1128/JCM.00593-12. Epub 2012 May 30.

19.
20.

Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States foodnet multicenter retrospective cohort study.

Crump JA, Kretsinger K, Gay K, Hoekstra RM, Vugia DJ, Hurd S, Segler SD, Megginson M, Luedeman LJ, Shiferaw B, Hanna SS, Joyce KW, Mintz ED, Angulo FJ; Emerging Infections Program FoodNet and NARMS Working Groups.

Antimicrob Agents Chemother. 2008 Apr;52(4):1278-84. doi: 10.1128/AAC.01509-07. Epub 2008 Jan 22.

Supplemental Content

Support Center